FindTrial
Sign In

Clinical Evaluation of the Efficacy of Integrative Treatment on Diminished Ovarian Reserve in Infertility

Clinical Evaluation of the Efficacy of Integrative Treatment on Diminished Ovarian Reserve in Infertility

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INC-16007849
Enrollment
Unknown
Registered
2016-01-28
Start date
2016-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diminished ovarian reserve in infertility

Interventions

Group 1:TCM which consisted with nourishing kidney and promoting blood circulation herbs
Group2:Progynova+Ethinyl Estradiol
Group3:Integrative Treatment

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: ? femal 20-40 years old; ? 7.9 2 and FSH>7;FSH/LH>2 and E2>80pg/ml(one in three above); ? with a history of infertility or spontaneous abortion; ? Sign the informed consent.

Exclusion criteria

Exclusion criteria: ? with severe heart, Liver, kidney, or brain disease; serious body disease; malignant tumor; ? Vaginal bleeding of unknown origin; ? thyroid disease or hyperprolactinemia; ? other Infertility reasons such as the male factors, genetic factors, immune factors, infection genital tract, or anatomy anomalies; ? For nearly three months use of sex hormone drugs or taking part in other clinical trials; ? not sign the informed consent.

Design outcomes

Primary

MeasureTime frame
FSH;T;—

Secondary

MeasureTime frame
pregnancy rate;Poor ovary reserve Traditional Chinese Medicine syndrome features Score;—

Countries

China

Contacts

Public ContactWang Wen jun
wjwwang@aliyun.com+86 13818607938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026